Arrowhead’s Redemplo secures Australian TGA approval for FCS therapy
The approval marks an expansion of access for a genetic disorder estimated to affect one to 13 people per million worldwide.
Drug Development
Novo Nordisk to launch Ozempic for type 2 diabetes in US
Axsome receives FDA approval for Auvelity to treat Alzheimer’s agitation
LEO Pharma to acquire gene therapy company Replay
Ray Therapeutics receives EMA PRIME status for gene therapy
Regeneron Q1 2026 net income falls 10% to $727m
Arcera and Fosun sign MoU for neuroscience innovation
Rocket to sell PRV for $180m to advance gene therapy pipeline
